NIAID DAIDS Science HIV Vaccines HIV/AIDS Treatment HIV/AIDS Prevention NIAID Home
NEWS | OVERVIEW | GENERAL INFORMATION | FUNDING OPPORTUNITIES
SCIENCE | RESOURCES & LINKS | STATUS OF HIV VACCINE RESEARCH | VACCINE STUDIES | HIV VACCINE TRIALS NETWORK

Vaccine Pre-clinical Toxicology Testing

Vaccine Designs/Concepts

Correlates of Immunity

Assay Development

Animal Models

Immunologic Adjuvants

Variation

International Studies

Behavior

Ethics

Vaccine Design and Methodologic Issues

Assay Validation


Vaccine Pre-clinical Toxicology Testing

by P.Y. Chang, Ph.D.1, CDR Rebecca Sheets, Ph.D.2,
Stuart Shapiro, M.D., Ph.D.3, Sally Hargus, Ph.D.,4
and Marion Gruber, Ph.D.4

Scope of this document

Introduction

Flowchart 1: Product Development of a Vaccine Candidate

Brief Overview of Vaccine Manufacture

Flowchart 2: Vaccine Manufacture

Pre-clinical Safety Testing of Candidate Vaccines

Flowchart 3: Pre-clinical Safety Testing

Pre-IND and IND Submissions

Flowchart 4: Preparing an Investigational New Drug Application

Summary

Glossary

Acknowledgements

About the authors

Additional flowchart detail



1 SRI International, Menlo Park, CA
2 U.S. Public Health Service, NIH/NIAID, Bethesda, MD
3 NIH/NIAID/Div. of AIDS, Bethesda, MD
4 FDA/CBER/Office of Vaccines Research & Review/Div. of Vaccines & Related Products Applications, Rockville, MD

Navigation Contact Us Vaccine Home Site Map DAIDS Home NIAID Home Search NIAID
Last updated January 23, 2003 (cs)